Cornel iridoid glycoside suppresses tau hyperphosphorylation and aggregation in a mouse model of tauopathy through increasing activity of PP2A.

CONCLUSION: CIG might have the potential to treat tauopathy such as AD via activating PP2A.
PMID: 31902362 [PubMed - as supplied by publisher]

Source: Current Alzheimer Research - January 1, 2020 Category: Neurology Authors: Ma D, Luo Y, Huang R, Zhao Z, Wang Q, Li L, Zhang L Tags: Curr Alzheimer Res Source Type: research